Point72 Hong Kong’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-686
Closed -$282K 577
2024
Q2
$282K Sell
686
-1,917
-74% -$759K 0.02% 283
2024
Q1
$1.05M Buy
2,603
+1,299
+100% +$457K 0.05% 262
2023
Q4
$400K Buy
+1,304
New +$352K 0.02% 376
2022
Q4
Sell
-898
Closed -$141K 1040
2022
Q3
$141K Buy
898
+616
+218% +$98.3K ﹤0.01% 1141
2022
Q2
$42K Buy
+282
New +$40.8K ﹤0.01% 1408
2021
Q3
Sell
-446
Closed -$79K 2264
2021
Q2
$79K Buy
446
+181
+68% +$31.2K ﹤0.01% 1374
2021
Q1
$43K Buy
+265
New +$40.5K ﹤0.01% 1312
2020
Q1
Sell
-131
Closed -$11K 1184
2019
Q4
$11K Buy
+131
New +$10.1K ﹤0.01% 970
2019
Q2
Sell
-21
Closed -$1K 1286
2019
Q1
$1K Buy
+21
New +$1.25K ﹤0.01% 947
2018
Q3
Sell
-310
Closed -$13K 1065
2018
Q2
$13K Buy
+310
New +$12.5K ﹤0.01% 627
2017
Q3
Sell
-16
Closed 948
2017
Q2
$0 Buy
+16
New +$449 ﹤0.01% 945

Other funds holding MEDP

Point72 Hong Kong's MEDP Position: Q3 2024 in Review

Point72 Hong Kong sold out of Medpace (MEDP) in Q3 2024, closing a stake of 686 shares — an estimated $282K sold.

Point72 Hong Kong first reported a position in MEDP in Q2 2017 and held it in 11 quarters. The position peaked at $1.05M in Q1 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • Point72 Hong Kong reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 686 Medpace shares in Q3 2024, an estimated $282K.
  • Point72 Hong Kong first reported a position in Medpace in Q2 2017 and held it in 11 quarters.
  • Point72 Hong Kong's Medpace position peaked at $1.05M in Q1 2024.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Point72 Hong Kong's 13F filing for Q3 2024, filed 14 Nov 2024.